BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12612967)

  • 1. Carnitine and hemodialysis.
    Bellinghieri G; Santoro D; Calvani M; Mallamace A; Savica V
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S116-22. PubMed ID: 12612967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in carnitine in chronic uremia.
    Guarnieri G; Biolo G; Vinci P; Massolino B; Barazzoni R
    J Ren Nutr; 2007 Jan; 17(1):23-9. PubMed ID: 17198928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine metabolism in uremia.
    Guarnieri G; Situlin R; Biolo G
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S63-7. PubMed ID: 11576925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnitine replacement in end-stage renal disease and hemodialysis.
    Calvani M; Benatti P; Mancinelli A; D'Iddio S; Giordano V; Koverech A; Amato A; Brass EP
    Ann N Y Acad Sci; 2004 Nov; 1033():52-66. PubMed ID: 15591003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. History of L-carnitine: implications for renal disease.
    Matera M; Bellinghieri G; Costantino G; Santoro D; Calvani M; Savica V
    J Ren Nutr; 2003 Jan; 13(1):2-14. PubMed ID: 12563618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysis-related carnitine disorder.
    Hedayati SS
    Semin Dial; 2006; 19(4):323-8. PubMed ID: 16893411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-carnitine supplementation in the dialysis population: are Australian patients missing out?
    Reuter SE; Faull RJ; Evans AM
    Nephrology (Carlton); 2008 Feb; 13(1):3-16. PubMed ID: 18199095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking--or were they?
    Steinman TI; Nissenson AR; Glassock RJ; Dickmeyer J; Mattern WD; Parker TF; Hull AR
    Nephrol News Issues; 2003 Apr; 17(5):28-30, 32-4, 36 passim. PubMed ID: 12715624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-carnitine in dialysis patients.
    Ahmad S
    Semin Dial; 2001; 14(3):209-17. PubMed ID: 11422928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnitine in maintenance hemodialysis patients.
    Guarnieri G
    J Ren Nutr; 2015 Mar; 25(2):169-75. PubMed ID: 25600394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Debate forum: levocarnitine therapy is rational and justified in selected dialysis patients.
    Schreiber BD
    Blood Purif; 2006; 24(1):128-39. PubMed ID: 16361853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L carnitine in hemodialysis patients.
    Calò LA; Vertolli U; Davis PA; Savica V
    Hemodial Int; 2012 Jul; 16(3):428-34. PubMed ID: 22360675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered carnitine metabolism in dialysis patients with reduced physical function may be due to dysfunctional fatty acid oxidation.
    Murphy WJ; Steiber A; Connery GC; Carder J; Spry L; Hoppel C
    Nephrol Dial Transplant; 2012 Jan; 27(1):304-10. PubMed ID: 21765185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carnitine nutriture of dialysis patients.
    Borum PR; Taggart EM
    J Am Diet Assoc; 1986 May; 86(5):644-7. PubMed ID: 3700927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of carnitine in modulating acute-phase protein synthesis in hemodialysis patients.
    Bellinghieri G; Santoro D; Calvani M; Savica V
    J Ren Nutr; 2005 Jan; 15(1):13-7. PubMed ID: 15648000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effect of intravenous l-carnitine on quality of life in chronic hemodialysis patients.
    Semeniuk J; Shalansky KF; Taylor N; Jastrzebski J; Cameron EC
    Clin Nephrol; 2000 Dec; 54(6):470-7. PubMed ID: 11140808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of low dose supplementation of L-carnitine on lipid metabolism in hemodialyzed children.
    Glöggler A; Bulla M; Fürst P
    Kidney Int Suppl; 1989 Nov; 27():S256-8. PubMed ID: 2636667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients.
    Sakurauchi Y; Matsumoto Y; Shinzato T; Takai I; Nakamura Y; Sato M; Nakai S; Miwa M; Morita H; Miwa T; Amano I; Maeda K
    Am J Kidney Dis; 1998 Aug; 32(2):258-64. PubMed ID: 9708610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.